European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Anaxomics Biotech SL, Barcelona, Spain

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Anaxomics Biotech SL

Register

Regmer
Registro Mercantil B64630569
Lei
959800YUNYQURSSB0Q37

Address

CA Balmes 00086, 08008 Barcelona, Spain

Additional info

72.19
Other research and experimental development on natural sciences and engineering
72.11
Research and experimental development on biotechnology

Financials

History

Marketing & Tech

Network

Loading network
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Publications

15 Apr 2024
No longer Officer (6)
7 Mar 2024
No longer Officer (2)
19 Jan 2024
Officer: Jose Mas Benavente
19 Jan 2024
Officer: M. Ramirez Vazquez
19 Jan 2024
Officer: J. Farres Marisch
18 Jan 2024
Director: Peter M. Windisch · No longer Director: Jose Mas Benavente
27 Dec 2023
Capital: €96,927
27 Apr 2023
Officer: L. Artigas Matilla, M. Coma Camprodon
2 Jan 2023
Auditor: J. Oriols Viaplana
1 Dec 2022 in Fts
EU funding (€352,302): 101095679 - Halt-Ronin - Discovering Chronic Inflammation Biomarkers That Define KEY Stages in the Healthy-to-Nash (NON-Alcoholic Steatohepatitis) Transition to Inform Early …
25 Nov 2022
Capital: €77,541
24 Mar 2021
Director: Jose Mas Benavente · No longer Director: Ramon Banet Andujar
25 Jan 2021
Officer: L. Artigas Matilla
25 Jan 2021
Officer: M. Coma Camprodon
25 Jan 2021
Officer: J. Farres Marisch
1 Jan 2021 in Fts
EU funding (€250,907): 956148 - Protrein - Computational Proteomics Training European Innovative Network
21 Aug 2020 in Hor
EU funding (€250,905): Computational Proteomics Training European Innovative Network
Year 2020 in Fts
6 EU fundings (total €641,126): 847749 - Recognised - Retinal and Cognitive Dysfunction in Type 2 Diabetes: Unraveling the Common Pathways and Identification of Patients AT Risk of Dementia …
1 Jan 2020 in Hor
EU funding (€428,250): A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.
1 Jan 2020 in Hor
EU funding (€212,871): Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe
Year 2019 in Hor
5 EU fundings (€275,219): Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia …
25 Nov 2019
Address
8 Nov 2019
Auditor: J. Oriols Viaplana
Year 2019 in Fts
7 EU fundings (total €1,020,731): 859962 - Secret - Exploitation of the Secretory Pathway for Cancer Therapy to Address European Research …
1 Jan 2018 in Fts
EU funding (€240,567): 765158 - Cosmic - Combatting Disorders of Adaptive Immunity with Systems Medicine
12 Dec 2017
Capital: €108,447
1 Nov 2017 in Fts
EU funding (€240,418): 765912 - Drive - Driving Next Generation Autophagy Researchers Towards Translation
10 Oct 2017 via Biotecture
EU funding (€247,873): COmbatting disorders of adaptive immunity with Systems MedICine
10 Oct 2017 via COST action Transautophagy
EU funding (€247,873): Driving next generation autophagy researchers towards translation
3 May 2017
Auditor: J. Oriols Viaplana
3 May 2017
Director: Ramon Banet Andujar, Jose Mas Benavente · No longer Chair of the board: Jose Mas Benavente · No longer Secretary: Ramon Banet Andujar · No longer Member of the board (3)
1 Jan 2017 in Fts
EU funding (€223,875): 731875 - Liverhope - Simvastatin and Rifaximin AS New Therapy for Patients with Decompensated Cirrhosis
15 Dec 2016 in Hor
EU funding (€223,875): SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
23 Sept 2016 in Hor
EU funding: Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia
16 Oct 2015
Patent: New Combination Therapies for Treating Neurological Damage
13 Aug 2014
Chair: Jose Mas Benavente · Board: Jose Mas Benavente, Ramon Banet Andujar, Sardon Urtiaga Teres · PPA: Jose Mas Benavente · Secretary: Ramon Banet Andujar · No longer Director: Jose Mas Benavente
13 May 2014
Auditor: J. Oriols Viaplana
17 Jan 2014
Patent: New Combination Therapies for Treating Nervous System Diseases
7 Jan 2014
Patent: Combination Therapies for Treating Ocular Disorders
Year 2013 in Fts
6 EU fundings (total €1,741,133): Grant FP7 - 613549 - Indox …
1 Aug 2013
Director: Jose Mas Benavente · No longer Director (1)
1 Aug 2013
Officer: Patricio Aloy Calaf, Ramon Banet Andujar
25 Oct 2012
Patent: New Combination Therapies for Treating Neurological Disorders
1 Sept 2012 in Fts
EU funding: Prolonged Inhibition of Semaphorine3a Pathway via a bio-Degradable Implant Towards a Better Therapy for Visual Sensory Impairments
1 Sept 2012 in Fts
EU funding: Prolonged Inhibition of Semaphorine3a Pathway via a bio-Degradable Implant Towards a Better Therapy for Visual Sensory Impairments
1 Apr 2012 in Fts
EU funding (€205,384): Rheumatoid Arthritis and Periodontal Inflammatory Disease (Rapid)
20 Jul 2011
Capital: €103,023
12 Jul 2011
No longer Director (3) · Director (1) · Address
1 Nov 2010 in Fts
EU funding (€147,840): Gums and Joints
26 Oct 2010
Patent: Methods and Systems for Identifying Molecules or Processes of Biological Interest by Using Knowledge Discovery in Biological Data
4 Sept 2009
Director (1)
1 Feb 2009 in Fts
EU funding: Antipathogn

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Anaxomics Biotech SL, Barcelona, Spain" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close